pI: 8.4569 |
Length (AA): 289 |
MW (Da): 31259 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 120 | 2awf (A) | 1 | 131 | 27.00 | 0 | 1 | 0.83 | -1.41 |
5 | 166 | 1ayz (A) | 2 | 154 | 23.00 | 0 | 1 | 0.82 | -0.75 |
6 | 170 | 3k9o (A) | 6 | 168 | 34.00 | 0.000000000078 | 1 | 0.951134 | -0.3 |
7 | 147 | 3bzh (A) | 47 | 190 | 23.00 | 0 | 0.91 | 0.873189 | -1.12 |
11 | 117 | 2fo3 (A) | 10 | 116 | 23.00 | 0 | 0.97 | 0.752542 | -1.25 |
45 | 109 | 1yf9 (A) | 46 | 110 | 40.00 | 0.00000071 | 0.39 | 0.546113 | -0.32 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128268)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G50430 | ubiquitin-conjugating enzyme 33 |
Arabidopsis thaliana | AT1G17280 | ubiquitin-conjugating enzyme E2 34 |
Brugia malayi | Bm1_42605 | ubiquitin conjugating enzyme 6 |
Candida albicans | CaO19.7347 | ubiquitin-conjugating enzyme |
Caenorhabditis elegans | CELE_Y110A2AM.3 | Protein UBC-26 |
Dictyostelium discoideum | DDB_G0286511 | hypothetical protein |
Dictyostelium discoideum | DDB_G0294380 | hypothetical protein |
Drosophila melanogaster | Dmel_CG5823 | CG5823 gene product from transcript CG5823-RB |
Echinococcus granulosus | EgrG_001188800 | ubiquitin conjugating enzyme E2 J2 |
Entamoeba histolytica | EHI_150370 | ubiquitin-conjugating enzyme family protein |
Echinococcus multilocularis | EmuJ_001188800 | ubiquitin conjugating enzyme E2 J2 |
Giardia lamblia | GL50803_6524 | Ubiquitin-conjugating enzyme E2-28.4 kDa |
Homo sapiens | ENSG00000160087 | ubiquitin-conjugating enzyme E2, J2 |
Leishmania braziliensis | LbrM.20.0870 | ubiquitin-conjugating enzyme e2, putative |
Leishmania braziliensis | LbrM.20.0900 | ubiquitin-conjugating enzyme e2, putative |
Leishmania braziliensis | LbrM.20.0890 | ubiquitin-conjugating enzyme e2, putative |
Leishmania donovani | LdBPK_340950.1 | ubiquitin-conjugating enzyme E2, putative |
Leishmania infantum | LinJ.34.0950 | ubiquitin-conjugating enzyme e2, putative |
Leishmania major | LmjF.34.0900 | ubiquitin-conjugating enzyme e2, putative |
Leishmania mexicana | LmxM.33.0900 | ubiquitin-conjugating enzyme e2, putative |
Loa Loa (eye worm) | LOAG_03681 | ubiquitin conjugating enzyme 6 |
Mus musculus | ENSMUSG00000023286 | ubiquitin-conjugating enzyme E2J 2 |
Neospora caninum | NCLIV_066720 | cDNA clone:001-047-D04, full insert sequence, related |
Oryza sativa | 4340379 | Os06g0193000 |
Saccharomyces cerevisiae | YER100W | E2 ubiquitin-conjugating protein UBC6 |
Schistosoma japonicum | Sjp_0049480 | ko:K04554 ubiquitin-conjugating enzyme E2 J2, putative |
Schistosoma mansoni | Smp_059750.1 | ubiquitin-conjugating enzyme E2 j2 |
Schistosoma mansoni | Smp_059750.2 | ubiquitin-conjugating enzyme E2 j2 |
Schmidtea mediterranea | mk4.001006.00 | Ubiquitin-conjugating enzyme E2 J2 |
Schmidtea mediterranea | mk4.000544.12 | Ubiquitin-conjugating enzyme E2 J2 |
Schmidtea mediterranea | mk4.003904.02 | Ubiquitin-conjugating enzyme E2 J2 |
Schmidtea mediterranea | mk4.000544.08 | Ubiquitin-conjugating enzyme E2 J2 |
Schmidtea mediterranea | mk4.003910.04 | Ubiquitin-conjugating enzyme E2 J2 |
Schmidtea mediterranea | mk4.004804.02 | Ubiquitin-conjugating enzyme E2 J2 |
Trypanosoma brucei gambiense | Tbg972.4.3470 | ubiquitin-conjugating enzyme e2, putative,ubiquitin carrier protein, putative,ubiquitin-protein ligase, putative |
Trypanosoma brucei gambiense | Tbg972.4.3220 | ubiquitin-conjugating enzyme e2, putative,ubiquitin carrier protein, putative,ubiquitin-protein ligase, putative |
Trypanosoma brucei | Tb927.4.3460 | ubiquitin-conjugating enzyme E2, putative |
Trypanosoma brucei | Tb927.4.3190 | ubiquitin-conjugating enzyme E2, putative |
Trypanosoma cruzi | TcCLB.504055.81 | ubiquitin-conjugating enzyme E2, putative |
Trypanosoma cruzi | TcCLB.506435.300 | ubiquitin-conjugating enzyme E2, putative |
Toxoplasma gondii | TGME49_208570 | ubiquitin conjugating enzyme E2, putative |
Toxoplasma gondii | TGME49_251640 | ubiquitin-conjugating enzyme subfamily protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.3190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.3190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.3190 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.4.3190 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.4.3460 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.3460 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.3460 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.3460 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_208570 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_251640 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.